CNTB jumps after Phase 2 COPD trial reports 100% reduction in return ED/hospital visits at one month
Market Chameleon (Wed, 30-Sep 9:51 AM)
CNTB climbs after Phase 2 asthma data shows 130 mL FEV1 edge at Day 7 and a 66% drop in treatment failures
Market Chameleon (Wed, 16-Sep 11:05 AM)
